Different approaches for treating myopic choroidal neovascularization: a network Meta-analysis [PDF]
International Journal of Ophthalmology, 2023 AIM: To evaluate the efficacy of intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF), photodynamic therapy (PDT), and laser treatment (LT) for anatomical and functional improvement in myopic choroidal neovascularization (mCNV ...
Ya-Jun Wu +4 more
doaj +2 more sources
Insights into myopic choroidal neovascularization based on quantitative proteomics analysis of the aqueous humor [PDF]
BMC Genomics, 2023 Background Previous studies on the biomarkers of pathologic myopia choroidal neovascularization (pmCNV) development merely detected limited types of proteins and provide a meagre illustration of the underlying pathways.
Huimin Yu +7 more
doaj +2 more sources
Characteristics and response of subretinal hyperreflective material to anti-vascular endothelial growth factor in myopic choroidal neovascularization [PDF]
Scientific Reports, 2023 This retrospective study evaluated the characteristics and response of subretinal hyperreflective material (SHRM) to anti-vascular endothelial growth factor (VEGF) treatment in eyes with myopic choroidal neovascularization (CNV).
Chien-Jung Huang +6 more
doaj +2 more sources
Association between choriocapillaris flow deficit and choroidal neovascularization activity in eyes with myopic choroidal neovascularization [PDF]
Scientific Reports, 2021 Although choriocapillaris flow deficit (CFD) around choroidal neovascularization (CNV) is less associated with CNV activity in myopic eyes, no reports are investigating its size as an indicator of CNV activity.
Sato Uematsu +9 more
doaj +2 more sources
Current and emerging treatment options for myopic choroidal neovascularization
Clinical Ophthalmology, 2015 Leila El Matri, Ahmed Chebil, Fedra Kort Department B of Ophthalmology, Hedi Rais Institute of Ophthalmology, Faculty of Medicine of Tunis, University of El Manar, Tunis, Tunisia Abstract: Choroidal neovascularization (CNV) is the main cause of visual ...
El Matri L, Chebil A, Kort F
doaj +1 more source
The Real-World Results of the Single Intravitreal Injection of Faricimab in Treatment-Naïve Subfoveal Myopic Choroidal Neovascularization [PDF]
MedicinaBackground and Objectives: Myopic choroidal neovascularization (mCNV) is a vision-threatening complication of pathologic myopia. While anti-VEGF monotherapy is the current standard of care, recurrence and suboptimal responses remain challenges. Faricimab
Hao-Chun Chang +9 more
doaj +2 more sources
Result of intravitreal aflibercept injection for myopic choroidal neovascularization [PDF]
BMC Ophthalmology, 2021 Background The current study aimed to evaluate the efficacy of intravitreal aflibercept injections as the primary treatment for subfoveal/juxtafoveal myopic choroidal neovascularization (CNV) by using optical coherence tomography (OCT). Optical coherence
Shih-Lin Chen +2 more
doaj +2 more sources
Case Reports in Ophthalmological Medicine, 2015 To date, choroidal blood flow reduction in highly myopic eyes appears to be related to the development of choroidal neovascularization secondary to local reduction of arterial flow.
Massimiliano Farina +2 more
doaj +2 more sources
Clinical Ophthalmology, 2017 Dimitrios Karagiannis,1 Georgios A Kontadakis,1,2 Konstantinos Kaprinis,1 Athanassios Giarmoukakis,2 lias Georgalas,3 Efstratios A Parikakis,1 Miltiadis K Tsilimbaris2 1Ophthalmiatreio Eye Hospital of Athens, Athens, Greece; 2Department of Ophthalmology,
Karagiannis D +6 more
doaj +1 more source
Efficacy and safety of intravitreal anti-VEGF for myopic choroidal neovascularization [PDF]
International Journal of OphthalmologyAIM: To report the 24mo outcomes of vascular endothelial growth factor (VEGF) inhibitors for myopic choroidal neovascularization (mCNV) in routine clinical practice and simultaneously evaluated the real-world safety.
Jing-Yao Liu, Ju-Ping Liu, Xiao-Rong Li
doaj +2 more sources